Lince Capital Research
Investment Thesis
Lince Capital is an independent Portuguese venture capital and specialized investment fund manager based in Lisbon, regulated by the CMVM (Portuguese Securities Market Commission, license PT.135.267). Founded in 2016 by Vasco Pereira Coutinho, the firm's mission is "to create value for the subscribers of investment funds and venture capital through professional and innovative management of their assets." Lince operates a deliberately diversified strategy across real estate, healthcare, technology, retail, and industrial sectors, backing both established small-to-medium enterprises and early-stage startups with high growth potential. The firm positions itself as an active, hands-on partner rather than a passive check-writer: it becomes a shareholder and operational partner, providing technical, financial, administrative, and commercial support, and runs rigorous technical-economic and feasibility studies before committing capital.
Stage Focus
Lince's venture capital arm concentrates on Portuguese seed and early-stage technology and healthcare companies, but the firm's broader fund platform also participates in later-stage growth rounds for portfolio standouts — for example continuing to back Sword Health through its Series E and Feedzai through a large growth round. In parallel, several of Lince's funds (Navigator, Navigator II, and a cluster of specialized real estate/hospitality vehicles) invest in mature real estate and hospitality assets rather than venture-stage equity. Overall the firm spans pre-seed/seed technology bets through growth-stage participation and real asset investment.
Check Size
Individual check sizes are not disclosed publicly. Lince deploys capital through a family of €9M–€146M funds (the Lince Innovation Fund series I–VI, Lince Growth Fund I, and Lince Yield Fund), giving it flexibility to write both small first checks into Portuguese startups and larger participations in growth rounds alongside international co-investors.
Lead Tendency
In its highest-profile recent deals, Lince has appeared as a participating investor rather than a lead: Sword Health's $40M Series E was led by General Catalyst with Lince alongside Comcast Ventures, Oxy Capital, Khosla Ventures, Indico Capital, Armilar, and Shilling; Feedzai's ~$75M round added Lince as a new institutional investor alongside Iberis Capital and Explorer Investments; and Neuraspace's €15.6M Series B included Lince alongside Explorer Investments and Armilar Venture Partners. The firm's own funds (e.g., Lince Growth Fund I, Lince Innovation Fund) likely lead smaller, earlier Portuguese deals, but no primary source confirms a lead role on a named venture round.
Recent Activity
Lince has been actively deploying in 2025–2026:
- June 2025: Participated in Sword Health's $40M Series E, valuing the company at $4B.
- October 2025: Joined Feedzai's ~$75M round as a new institutional investor, pushing Feedzai's valuation past $2B ahead of its ECB digital-euro fraud-prevention contract.
- November 2025: Forbes Portugal reported Lince had invested €140M across 36 companies (34 Portuguese) since founding, and was raising Lince Innovation Fund V (targeting €20M, 10-year term, 3-year investment period) for Portuguese technology and healthcare companies.
- February–March 2026: Portfolio company Cargofive (ocean freight rate platform) was acquired by Germany's cargo.one, which used the deal to launch an AI-native multimodal freight operating system.
- August 2026: Participated in Neuraspace's €15.6M Series B to expand its AI-driven Space Domain Awareness platform, alongside Explorer Investments and Armilar Venture Partners.
Portfolio Highlights
Lince's portfolio spans roughly 50 companies. Notable names include two Portuguese unicorns — Sword Health (AI-powered digital physical/mental therapy, ~$4B valuation) and Feedzai (RiskOps/fraud-prevention platform, >$2B valuation, selected by the European Central Bank for digital-euro fraud prevention) — plus Coverflex (employee benefits fintech), Nutrium (nutrition practice software), Cargofive (freight-forwarding SaaS, exited to cargo.one in 2026), Neuraspace (space domain awareness), iLoF (AI-driven biomarker discovery), Musiversal (remote music production marketplace), and Kencko (smoothie/nutrition consumer brand). The firm also holds a large book of real estate and hospitality assets (e.g., several boutique hotels and mixed-use developments in Lisbon, Porto, and the Algarve) through its Navigator and specialized real estate funds, which sit alongside the venture book rather than being typical startup investments.
Team
Lince Capital runs roughly 25–30 dedicated professionals across venture capital, private equity, legal, finance, and investor relations functions. Key people:
- Vasco Pereira Coutinho — CEO (also founder of Lince Real Estate)
- Tomás Lavin Peixe — Head of Venture Capital
- Rodrigo Duarte — Head of Private Equity
- Lourenço Mayer — Head of Growth Funds
- Afonso Próspero — Head of Legal
- Raquel Costa — Head of Finance
- Francisco Sottomayor — Head of Investor Relations
- Madalena Lisboa — Head of Marketing & Communications
- Rui Fonte — Venture Capital Senior Analyst
- Francisco Costa — Venture Capital Associate
- Francisco Guedes — Venture Capital Analyst
- Marta Botelho Afonso — Venture Capital Junior Analyst
- The firm also works with outside investment advisors at Omnium Advisory Partners (António Caleia, Francisco Formigal Pinto, Afonso Pinheiro) on M&A and deal sourcing.
Decision Process
Lince operates as a structured partnership with functional heads (VC, Private Equity, Growth Funds, Legal, Finance) reporting into CEO Vasco Pereira Coutinho, supported by dedicated analysts and associates per vertical and external investment advisors for deal sourcing and M&A support. This points to a partnership/committee-style process rather than a solo-GP model, though the exact investment committee structure is not publicly documented.
Founder Preferences
Public materials emphasize "projects with high growth potential" where Lince's team can add hands-on operational, technical, financial, administrative, and commercial support. The firm favors Portuguese-founded or Portuguese-headquartered teams, particularly in technology, healthcare, and industrial/circular-economy niches, and has shown willingness to back founders through multiple stages (seed through growth, as with Sword Health and Feedzai).
Geographic Focus
Overwhelmingly Portugal-based and Portugal-first: roughly 34 of 36 disclosed portfolio companies are Portuguese, and several funds are explicitly scoped to Portuguese companies (Lince Yield Fund, Lince Growth Fund I, Lince Innovation Fund). The firm does back companies with European/international expansion ambitions (Feedzai, Sword Health, Neuraspace all operate internationally) and its investor base spans 50+ nationalities, but the sourcing and portfolio concentration remains centered on Lisbon and the broader Portuguese startup ecosystem.